Ptc Therapeutics (PTCT) Work In Process (2019 - 2026)

Ptc Therapeutics' Work In Process history runs 8 years deep, the most recent figure standing at $52.8 million for Q1 2026.

• On a quarterly basis, Work In Process rose 304.07% year-over-year to $52.8 million in Q1 2026; TTM through Mar 2026 was $52.8 million, a 304.07% increase from a year earlier, with the FY2025 full-year figure at $55.7 million, up 355.84% from the prior year.
• Work In Process declined to $52.8 million in Q1 2026 per PTCT's latest filing, from $55.7 million in the prior quarter.
• Across five years, Work In Process topped out at $55.7 million in Q4 2025 and bottomed at $7.0 million in Q2 2022.
• The 5-year median for Work In Process is $20.9 million (2023), against an average of $22.9 million.
• Biggest YoY gain for Work In Process was 355.84% in 2025; the steepest drop was 41.09% in 2025.
• Year by year, Work In Process stood at $14.1 million in 2022, then gained by 27.83% to $18.0 million in 2023, then slumped by 32.1% to $12.2 million in 2024, then jumped by 355.84% to $55.7 million in 2025, then decreased by 5.19% to $52.8 million in 2026.
• Per Business Quant, the three latest PTCT Work In Process figures stand at $52.8 million (Q1 2026), $55.7 million (Q4 2025), and $41.8 million (Q3 2025).